Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 3 years, the average Dividends Per Share Growth Rate was 5.90% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 12.60% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 9.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Merck KGaA was 59.50% per year. The lowest was -26.90% per year. And the median was 7.30% per year.
During the past 13 years, the highest Dividend Payout Ratio of Merck KGaA was 0.48. The lowest was 0.20. And the median was 0.31.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Merck KGaA Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
EUR 2.200000
2026-04-27
2026-04-28
2026-04-29
Cash Dividend
annually
EUR:CHF 0.907283
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Merck KGaA's Dividend Yield (%) for Today is calculated as
Current Share Price is CHF130.50.
Merck KGaA's Dividends per Share for the trailing twelve months (TTM) ended in Today is CHF1.9960226.
During the past 13 years, the highest Dividend Yield of Merck KGaA was 2.11%. The lowest was 0.62%. And the median was 1.29%.
Warning Sign:
Merck KGaA stock Dividend Yield % is close to 1-year low.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Merck KGaA 5-Year Dividend Growth Rate Related Terms
XSWX:MER vs ZTS, UTHR, VTRS: 5-Year Dividend Growth Rate Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Merck KGaA 5-Year Dividend Growth Rate vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's 5-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where Merck KGaA's 5-Year Dividend Growth Rate falls into.
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 5-Year Dividend Growth Rate of 12.60% mean?
Merck KGaA (XSWX:MER) has a 5-Year Dividend Growth Rate of 12.60% as of Mar. 2026. 5-Year Dividend Growth Rate is the company's five-year average growth of dividend payout. View historical data on Merck KGaA and its competitors. According to the industry distribution chart, Merck KGaA ranks #117 out of 280 companies in the Drug Manufacturers industry, placing it in the top 41.8%.
Is Merck KGaA's 5-Year Dividend Growth Rate too high?
Merck KGaA's current 5-Year Dividend Growth Rate is 12.60%. The Drug Manufacturers industry median 5-Year Dividend Growth Rate is 10.20. Merck KGaA's value of 12.60% is 23.5% above this industry median. Based on the distribution chart, Merck KGaA ranks #117 out of 280 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Merck KGaA has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Merck KGaA's 5-Year Dividend Growth Rate compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Merck KGaA ranks #117 out of 280 companies for 5-Year Dividend Growth Rate. This puts Merck KGaA in the upper half of its industry. The industry median 5-Year Dividend Growth Rate is 10.20. Merck KGaA's value of 12.60% is 23.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Dividend Growth Rate for a Drug Manufacturers company?
The median 5-Year Dividend Growth Rate among Drug Manufacturers companies is 10.20, based on 280 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Dividend Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Dividend Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Merck KGaA's current 5-Year Dividend Growth Rate of 12.60% is 23.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Dividend Growth Rate mean?
A high 5-Year Dividend Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year Dividend Growth Rate is the company's five-year average growth of dividend payout. View historical data on Merck KGaA and its competitors. For the Drug Manufacturers industry, the median 5-Year Dividend Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Merck KGaA's current 5-Year Dividend Growth Rate is 12.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merck KGaA stock overvalued right now?
Merck KGaA (XSWX:MER) has a current 5-Year Dividend Growth Rate of 12.60%. The stock's GF Value™ is CHF136.85, compared to a current price of CHF130.50 — trading 4.6% below its estimated fair value. The current 5-Year Dividend Growth Rate is 12.60% and 23.5% above the Drug Manufacturers industry median of 10.20. Merck KGaA's overall GF Score™ is 84/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Dividend Growth Rate calculated?
5-Year Dividend Growth Rate is calculated from a company's financial statements. For Merck KGaA (XSWX:MER), the current 5-Year Dividend Growth Rate is 12.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Merck KGaA (XSWX:MER) Overvalued in 2026?
Based on GuruFocus' analysis, Merck KGaA stock appears to be undervalued.
The current stock price of CHF130.50 is trading 4.6% below its estimated GF Value™ of CHF136.85.
Key valuation signals for XSWX:MER:
5-Year Dividend Growth Rate: 12.60%
GF Value™: CHF136.85 vs. price of CHF130.50 (4.6% below fair value)
Industry Position: 23.5% above the Drug Manufacturers median (#117 of 280)
No single metric tells the full story. See the XSWX:MER stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
84GF Score
Get the complete analysis for XSWX:MER
5-Year Dividend Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MER has been successfully added to your 
